Governments must change how they deliver health care
The focus has long been on the belief that more doctors and nurses equals better health care. While they’re the backbone of the system, we need to start looking at solutions differently.
Feds can no longer ignore devastation from substance use in the North
Northern-specific data is necessary to ensure the federal government is not swayed by popular southern theories.
Talent shortage a priority for biotech sector emerging from pandemic
Canada is likely to face a shortfall of about 65,000 workers in the bio-economy by 2029, according to BioTalent Canada.
Biotech Policy Briefing
Seizing the moment: building Canada’s academic leadership into a commercial powerhouse
Too much high-quality research is failing to make it out of laboratories to the benefit of patients and the Canadian economy.
New safety guidance sets up corporate self-regulation of GMOs
Health Canada and the Canadian Food Inspection Agency both recently updated their guidance on regulating genetically engineered foods and seeds.
Biotech sector is having a generational moment in Canada
It is not possible to predict what or when the next global health challenge will be, or what solutions will be needed.
Canada’s place in the world of biotechnology research and application is in jeopardy
Government of Canada funded scholarships and fellowships are the primary sources of income for many biotechnology researchers. To stem the brain-drain, Canada must significantly increase the value and number of graduate student scholarships and post-doctoral fellowships and to index them to the cost of living.
Can biotechnology put patients’ needs ahead of profits?
These are challenging dilemmas for a government that gutted a suite of policies designed to cap excessive drug prices, and that ‘waxed lyrical’ about the importance of accelerating vaccine access worldwide, then failed to support an intellectual property waiver that would expand global production of COVID-19 vaccines.
A national framework for fetal alcohol spectrum disorder is long overdue
Research has shown the societal cost of FASD in Canada tops $10.5-billion annually. These costs are incurred through criminal justice, health care, educational services, social services, and lost productivity.
